8-K: Adtalem Global Education Reports Strong Q3 Results, Raises Full-Year Guidance

Adtalem Global Education announced robust third-quarter fiscal 2024 results, highlighted by an 11.8% year-over-year revenue increase and a 7.8% rise in total enrollment, leading to an improved full-year outlook.

Summary

• Adtalem Global Education reported its fiscal third-quarter 2024 results, showing significant growth in revenue and enrollment.
• Revenue reached $412.7 million, an 11.8% increase compared to the same quarter last year.
• Total student enrollment grew by 7.8% year-over-year, reaching 85,809 students.
• Chamberlain University experienced its fifth consecutive quarter of enrollment growth, up 9.0% year-over-year, achieving its highest total enrollment in history.
• Walden University also saw its third straight quarter of enrollment growth, with an 8.4% year-over-year increase.
• The company's adjusted earnings per share (EPS) was $1.50, a 32.7% increase year-over-year.
• Adjusted EBITDA was $107.1 million, a 24.6% increase year-over-year, with an adjusted EBITDA margin of 25.9%.
• Adtalem repurchased $91 million of its shares during the quarter.
• The company has raised its full-year revenue guidance to $1,560 million to $1,580 million and adjusted EPS guidance to $4.80 to $5.00.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, enrollment growth, and increased guidance. The company's strategic initiatives and focus on healthcare education are also viewed favorably.

Positives

• Adtalem experienced strong revenue growth of 11.8% year-over-year.
• Total student enrollment increased by 7.8% year-over-year, indicating strong demand for their programs.
• Both Chamberlain and Walden Universities showed significant enrollment growth.
• Adjusted EPS increased by 32.7% year-over-year, demonstrating improved profitability.
• Adjusted EBITDA grew by 24.6% year-over-year, reflecting enhanced operational efficiency.
• The company's share repurchase program indicates confidence in its future performance.
• The increase in full-year guidance suggests positive expectations for the remainder of the fiscal year.
• The medical schools achieved a 98% first-time residency attainment rate for graduates.

Negatives

• Net income decreased to $36.8 million from $45.9 million in the prior year.
• Diluted earnings per share decreased to $0.93 from $1.00 in the prior year.
• Total student enrollment in the Medical and Veterinary segment decreased by 4.5% year-over-year.
• The home office and other segment had an operating loss of $27.9 million.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• The medical and veterinary segment experienced a decrease in total student enrollment.
• The company's financial results are subject to various factors, including changes in the regulatory environment and economic conditions.

Future Outlook

Adtalem has raised its full-year revenue guidance to a range of $1,560 million to $1,580 million and adjusted earnings per share guidance to a range of $4.80 to $5.00.

Management Comments

• Steve Beard, president and chief executive officer, stated that the company's Growth with Purpose strategy continues to accelerate topand bottom-line performance.
• He also noted that the momentum is built on strong enrollments, improved persistence, and outstanding academic outcomes.

Industry Context

Adtalem's strong performance reflects the growing demand for healthcare education in the U.S., as the company positions itself as a key provider of healthcare professionals. The company's focus on addressing nursing shortages and diversifying the physician pipeline aligns with broader industry trends.

Comparison to Industry Standards

• Adtalem's 11.8% revenue growth is strong compared to some other education providers, but it is important to compare this to specific competitors in the healthcare education sector.
• For example, companies like Strategic Education, Inc. (STRA) and Grand Canyon Education, Inc. (LOPE) also operate in the higher education space, and their growth rates and profitability metrics would be relevant for comparison.
• The 98% first-time residency attainment rate for Adtalem's medical schools is a very strong result, and it is likely higher than the average for medical schools in the US.
• The adjusted EBITDA margin of 25.9% is a good result, but it is important to compare this to the margins of other education companies to assess its relative performance.

Management Changes

Stakeholder Impact

• Shareholders will benefit from the increased revenue, profitability, and share repurchases.
• Employees will benefit from the company's growth and success.
• Students will benefit from the company's focus on providing high-quality, in-demand programs.
• The healthcare industry will benefit from the company's efforts to address workforce shortages and diversify the pipeline of healthcare professionals.

Next Steps

• Adtalem will continue to execute its Growth with Purpose strategy.
• The company will focus on expanding access to high-quality, in-demand programs.
• Adtalem will continue to invest in its specialized nursing education model.
• The company will continue to monitor and manage its financial performance.

Key Dates

Keywords

Adtalem Global Education, Healthcare Education, Enrollment Growth, Revenue Growth, Adjusted EPS, Adjusted EBITDA, Chamberlain University, Walden University, Medical Education, Nursing Education, Share Repurchase, Financial Results, Fiscal Third Quarter, Guidance Raised